Copyright
©The Author(s) 2025.
World J Cardiol. Jun 26, 2025; 17(6): 106717
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.106717
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.106717
Table 4 Echocardiographic parameters of the included patients
Variable | Transient improvement (n = 39) | Sustained improvement (n = 136) | P value |
Baseline (Echo-1) | |||
LVEF (%) | 30.56 ± 6.95 | 26.77 ± 7.05 | 0.003 |
Average E/e’ | 15.01 ± 5.88 (n = 20) | 14.52 ± 5.78 (n = 67) | 0.74 |
LA volume index (mL/m2) | 35.97 ± 12.51 (n = 25) | 37.09 ± 11.35 (n = 82) | 0.68 |
LVEDD (cm) | 5.76 ± 0.79 (n = 37) | 6.70 ± 4.17 (n = 130) | 0.18 |
LVESD (cm) | 4.76 ± 0.84 (n = 34) | 5.08 ± 0.89 (n = 115) | 0.80 |
RVSP (mmHg) | 33.46 ± 11.06 | 37.35 ± 12.89 (n = 130) | 0.13 |
Second follow-up (Echo-3) | |||
LVEF (%) | 28.46 ± 6.59 | 40.18 ± 0.12 | 0.001 |
Average E/e’ | 13.12 ± 5.46 (n = 19) | 12.08 ± 5.86 (n = 77) | 0.49 |
LA volume index (mL/m2) | 41.41 ± 12.92 (n = 31) | 34.30 ± 11.26 (n = 114) | 0.003 |
LVEDD (cm) | 6.06 ± 0.62 (n = 38) | 5.81 ± 0.89 (n = 134) | 0.05 |
LVESD (cm) | 4.99 ± 0.75 (n = 37) | 4.50 ± 0.95 (n = 131) | 0.004 |
RVSP (mmHg) | 38.78 ± 14.61 (n = 37) | 33.10 ± 11.82 (n = 129) | 0.04 |
LVEF (Echo-2) | 38.59 ± 7.57 | 36.33 ± 7.69 | 0.11 |
∆ LVEF (Echo-2 - Echo-1) (%) | 8.05 ± 6.53 | 9.54 ± 7.69 | 0.27 |
Duration between Echo-1 and Echo-2 (months) | 19.82 ± 26.61 | 17.24 ± 21.15 | 0.53 |
∆ LVEF (Echo-3 - Echo-1) (%) | -2.10 ± 5.05 | 13.43 ± 9.09 | 0.001 |
Duration between Echo-2 and Echo-3 (months) | 20.49 ± 13.40 | 21.79 ± 23.39 | 0.74 |
- Citation: Kaddoura R, Chapra A, Shah J, Izham M, Singh R, Alsadi H, Al-Amri M, Hamamyh T, Fallouh M, Elasad F, Abdelghani M, Alsaadi Alyafei S, Badr A, Patel A. Beyond initial recovery: Heart failure with transient vs sustained improvement in left ventricular ejection fraction. World J Cardiol 2025; 17(6): 106717
- URL: https://www.wjgnet.com/1949-8462/full/v17/i6/106717.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i6.106717